Digital asset investment firm Techemy Capital today announced the launch of its Managed DeFi Portfolio in partnership with Enzyme Finance, an on-chain asset manager formerly known as Melon Protocol. Techemy Capital will combine expertise and strategy based on years of internal proprietary trading through its discretionary and active portfolio management solution to provide wholesale and accredited investors with access to the full Ethereum DeFi ecosystem at competitive rates.
“We are delighted to provide this opportunity through Enzyme, where wholesalers and accredited investors can gain broad exposure to Ethereum’s DeFi ecosystem. Given the great performance of the private / in-house DeFi fund that we ran for the calendar year 2020 (closed + 411% USD) with the same thesis, I look forward to bringing this professional DeFi investment solution to the market. “
– Fran Strajnar, founder of Techemy Capital and Brave New Coin
Techemy Capital’s unique investment strategy, based on successful practices and risk management, allows investors to fully manage their assets through non-custodial storage, while eliminating the risk of human error by programming the portfolio architecture to behave within the preset parameters. Investors can withdraw their assets at any time and monitor portfolio performance 24/7 as blockchain technology ensures the validity, immutability and visibility of all transactions in the ledger.
In addition, Techemy Capital provides opportunities for investors to hedge their exposure to DeFi by obtaining insurance-like coverage against potential failed contracts through its partnerships with Nexus Mutual and Unslashed Finance.
The initial asset allocation of the managed DeFi portfolio includes Chainlink (LINK), Band Protocol (BAND), SushiSwap (SUSHI), Maker DAO (MKR), 0x Protocol (ZRX), Ren Protocol (REN), Aave (AAVE), Balancer Finance (BAL), Compound Network (COMP), Synthetix Network (SNX), Uniswap (UNI), Curve Finance (CRV), Bancor Network (BNT) and 1Inch Exchange (1INCH).